Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging — Stella

Recruiting

Back to COPD trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Robarts Research Institute; The University of Western Ontario; London Health Sciences Centre, London, Ontario

Key details

Sponsor

Dr. Grace Parraga

Collaborators

London Health Sciences Centre

Enrollment target

~200 participants

Started

May 2009

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years – 85 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov